> biologics are the top-sellers in 2018
This is true, and big pharma will continue to invest very heavily here, since these medications contain living organisms and are much harder/more expensive to make into "generic" versions.
This is true, and big pharma will continue to invest very heavily here, since these medications contain living organisms and are much harder/more expensive to make into "generic" versions.